| abstract |
Substituted tri-phenyl-phosphonium (TPP) derivative compounds, having a fatty acid moiety, have an improved selectivity for mitochondria to target bulk cancer cells, cancer stem cells, and normal senescent cells. The substituted TPP-derivatives described herein have efficacy for treating cancer, and in particular, preventing or reducing the likelihood of tumor recurrence and/or metastasis. |